Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of hyperhidrosis
3.2.1.2 Growing awareness and diagnosis rates
3.2.1.3 Advancements in treatment technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects and risk associated with treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Axillary hyperhidrosis
5.3 Palmar hyperhidrosis
5.4 Plantar hyperhidrosis
5.5 Other types
Chapter 6 Market Estimates and Forecast, By Treatment, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Topical treatment
6.3 Oral medication
6.3.1 Anticholinergics
6.3.2 Other oral medications
6.4 Botulinum toxin injections
6.5 Iontophoresis
6.6 Surgical treatment
Chapter 7 Market Estimates and Forecast, By Age, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Below 50 years
7.3 Above 50 years
Chapter 8 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Dermatology clinics
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AbbVie Inc.
10.2 Avanor Healthcare Ltd.
10.3 Brickell Biotech Inc.
10.4 Dermadry Laboratories Inc.
10.5 Dermavant Sciences Inc.
10.6 Hugel, Inc.
10.7 Eirion Therapeutics, Inc
10.8 Eli Lilly and Company
10.9 Intas Pharmaceuticals Ltd
10.10 Kaken Pharmaceutical Co., Ltd.
10.11 Maruho Co., Ltd.
10.12 miraDry, Inc.
10.13 SweatBlock
